Jalota Deepika
SEC CIK 1825192 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| PMVP | PMV Pharmaceuticals, Inc. | SVP, Regulatory Affairs, QA | 90.0K | — | $170.9K | 7 | 2021-08-17 | 2025-07-01 |
Most active insiders at PMVP, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | OrbiMed Capital GP V LLC | 10% | — | $1.52M |
| 2 | Mack David Henry | Pres, CEO, Dir | — | — |
Jalota Deepika made no open-market trades at PMVP in the last 12 months.
Transactions 7
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-07-03 | 2025-07-01 | PMVP | PMV Pharmaceuticals, Inc. | Jalota Deepika | Chief Development Off | S - Sale | $1.06 | -33.1K | 90.0K | -27% | -$35.0K | |
| 2024-09-12 | 2024-09-11 | PMVP | PMV Pharmaceuticals, Inc. | Jalota Deepika | Chief Development Off | S - Sale | $1.50 | -7,218 | 118.3K | -6% | -$10.8K | |
| D | 2024-01-22 | 2024-01-18 | PMVP | PMV Pharmaceuticals, Inc. | Jalota Deepika | Chief Development Off | A - Grant | $0.00 | +95.6K | 125.5K | +319% | $0 |
| 2023-09-18 | 2023-09-15 | PMVP | PMV Pharmaceuticals, Inc. | Jalota Deepika | Chief Development Off | S - Sale | $6.62 | -4,104 | 29.9K | -12% | -$27.2K | |
| 2022-09-13 | 2022-09-09 | PMVP | PMV Pharmaceuticals, Inc. | Jalota Deepika | SVP, Regulatory Affairs, QA | A - Grant | $0.00 | +34.0K | 34.0K | New | $0 | |
| D | 2021-08-18 | 2021-08-17 | PMVP | PMV Pharmaceuticals, Inc. | Jalota Deepika | SVP, Regulatory Affairs, QA | M - OptEx | $3.53 | +2,896 | 2,896 | New | +$10.2K |
| D | 2021-08-18 | 2021-08-17 | PMVP | PMV Pharmaceuticals, Inc. | Jalota Deepika | SVP, Regulatory Affairs, QA | S - Sale+OE | $33.78 | -2,896 | 0 | -100% | -$97.8K |
Purchase Sale Sale after option exercise All abbreviations